Global Life Science Ventures
31
20M
21
1.19
9
0.32
14
- Stages of investment
- Areas of investment
Summary
Global Life Science Ventures is the famous VC, which was founded in 1996. The company was established in Europe in Germany. The main office of represented VC is situated in the Mu00fcnchen.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Global Life Science Ventures, startups are often financed by Alta Partners, Gilde Healthcare, Canaan Partners. The meaningful sponsors for the fund in investment in the same round are Gilde Healthcare, Alta Partners, Forbion Capital Partners. In the next rounds fund is usually obtained by Gilde Healthcare, Van Herk Ventures, Thuja Capital.
For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular fund investment industries, there are Genetics, Marketing. Among the various public portfolio startups of the fund, we may underline Agendia, Coapt Systems, Binx Health The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager.
The top activity for fund was in 2003. The typical startup value when the investment from Global Life Science Ventures is 5-10 millions dollars. The real fund results show that this VC is 10 percentage points more often commits exit comparing to other companies. The usual things for fund are deals in the range of 10 - 50 millions dollars. Comparing to the other companies, this Global Life Science Ventures performs on 14 percentage points more the average number of lead investments. The higher amount of exits for fund were in 2005. The fund is constantly included in less than 2 investment rounds annually.
The overall number of key employees were 2.
Investments analytics
Analytics
- Total investments
- 31
- Lead investments
- 9
- Exits
- 14
- Rounds per year
- 1.19
- Follow on index
- 0.32
- Investments by industry
- Biotechnology (27)
- Health Care (18)
- Medical (17)
- Pharmaceutical (10)
- Health Diagnostics (6) Show 15 more
- Investments by region
-
- United States (10)
- Switzerland (6)
- Germany (6)
- Netherlands (3)
- Austria (1) Show 3 more
- Peak activity year
- 2004
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 21
- Avg. valuation at time of investment
- 32M
- Group Appearance index
- 0.97
- Avg. company exit year
- 10
- Avg. multiplicator
- 0.98
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Espresso Controle de Despesas | 01 Jan 2016 | Software, FinTech, B2B, Mobile, Finance, SaaS, Apps | Seed | Minas Gerais, Uberlândia, Brazil | |
Intercell | 18 Jul 2003 | Biotechnology, Health Care, Medical | Late Stage Venture | 50M | Austria, Vienna |
NeurogesX | 24 Feb 2004 | Biotechnology, Medical Device, Medical, Neuroscience | Late Stage Venture | 35M | United States, California |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.